8-epi-PGF2α, a Novel Noncyclooxygenase-derived Prostaglandin, Constricts Airways In Vitro

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 2, 1996, Pages 590-596

  Kawikova, Ivana ^b   Barnes, Peter J ^b   Takahashi, Tsuneyuki ^b   Tadjkarimi, Samad ^b   Yacoub, Magdi H ^b   Belvisi, Maria G ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DIOXANE DERIVATIVE; DRUG DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; THROMBOXANE A2; XANTHENE DERIVATIVE; XANTHONE DERIVATIVE; 8 ISOPROSTAGLANDIN F2 ALPHA; INDOMETACIN; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; BRONCHOSPASM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GUINEA PIG; HUMAN; IN VITRO STUDY; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PHYSIOLOGY; TRACHEA; ANIMAL CELL; ANIMAL TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR BLOCKING; TRACHEA COMPRESSION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADOLESCENT; ADULT; ANIMALS; BRONCHOCONSTRICTION; DINOPROST; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; F2-ISOPROSTANES; FEMALE; GUINEA PIGS; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RECEPTORS, PROSTAGLANDIN; THROMBOXANE A2; TRACHEA; XANTHENES; XANTHONES;

EID: 0029664977     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.2.8564103     Document Type: Article

References (23)

1. O'Connor, D. E., E. D. Mihelich, and M. C. Coleman. 1984. Stereochemical course of the autooxidative cyclization of lipid hydroperoxides to prostaglandin-like bicycloendoperoxides. J. Am. Chem. Soc. 106: 3577-3584.
2. Morrow, J. D., K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, and L. J. Roberts, II. 1990. A series of 8-epi-PGF2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:9383-9387.
3. Morrow, J. D., T. M. Harris, and L. J. Roberts. 1990. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramification for measurement of eicosanoids. Anal. Biochem. 184:1-10.
4. Morrow, J. D., T. A. Minton, C. R. Mukundan, M. D. Campbell, W. E. Zackert, V. C. Daniel, K. F. Badr, I. A. Blair, and L. J. Roberts, II. 1994. Free radical-induced generation of isoprostanes in vivo. J. Biol. Chem. 269:4317-4326.
5. 2α, is formed in vivo. Biochim. Biophys. Acta 1210:244-248.
6. 2α, in the rat. J. Clin. Invest. 90:136-141.
7. 2α, in rabbit lung in situ. Am. J. Physiol. 263:H660-H663.
8. 2α in isolated perfused rat lung. J. Appl. Physiol. 74:460-465.
9. Coleman, R. A., W. Smith, and S. Narumiya. 1994. VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptor and their subtypes. Pharmacol. Rev. 46:205-229.
10. 2α in the airways of human subjects Am. J. Respir. Cell Mol. Biol. 9:568-572.
11. Belvisi, M. G., R. Patacchini, P. J. Barnes, and C. A. Maggi. 1994. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic receptors on cholinergic neurotransmission: evidence for species differences. Br. J. Pharmacol. 111:103-110.
12. Coleman, R. A., and I. Kennedy. 1985. Characterization of the prostanoid receptors mediating contraction of guinea pig isolated trachea. Prostaglandins 29:363-375.
13. 2 receptor antagonist on smooth muscle. Br. J. Pharmacol 95:675P.
14. 1 receptor blocking drug. Br. J. Pharmacol. 85:273P.
15. Kenakin, T. 1993. Pharmacological Analysis of Drug-Receptor Interaction. Raven Press, New York. 483.
16. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264:C1619-C1624.
17. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44:155-163.
18. McKenniff, M., I. W. Rodger, P. Norman, and P. J. Gardiner. 1988. Characterisation of receptors mediating the contractile effects of prostanoids in guinea pig and human airways. Eur. J. Pharmacol. 153:149-159.
19. 2 receptor antagonist on airway smooth muscle in vitro. Br. J. Pharmacol. 104: 585-590.
20. Barnes, P. J. 1990. Reactive oxygen species and airway inflammation. Free Radic. Biol. Med. 9:235-243.
21. Smith, L. J., M. Shamsudin, and J. Anderson. 1994. Oxidant-antioxidant balance in lungs of patients with asthma (abstract). Am. Rev. Respir. Crit. Care Med. 149:A965.
22. 2 in the pathogenesis of airway hyperresponsiveness. Eur. Respir. J. 2:782-786.
23. 2 receptor anagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J. Allergy Clin. Immunol. 87:23-27.